Carbohydrate restriction reduces lipids and inflammation and prevents atherosclerosis in Guinea pigs

Journal of Atherosclerosis and Thrombosis

Volumn 15, Issue 5, 2008, Pages 235-243

  Torres Gonzalez, Moises ^a   Volek, Jeff S ^a   Leite, Jose O ^a   Fraser, Heather ^b   Fernandez, Maria Luz ^a  

^a UNIVERSITY OF CONNECTICUT   (United States)

^b Anthera Pharmaceuticals   (United States)

Author keywords

Aorta stiffness; Atherosclerosis; Cytokines; Low carbohydrate diet

Indexed keywords

EID: 56349164247     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.E5781     Document Type: Article

References (42)

1. Bonow RO, Smaha LA, Smith SC Jr., Mensah GA, and Lenfant C: World Heart Day 2002: the international burden of cardiovascular disease: responding to the emerging global epidemic. Circulation, 2002; 106:1602-1605
2. Karsch KR: Atherosclerosis - where are we heading? Herz, 1992; 17:309-319
3. Dennis EA: Diversity of group types, regulation, and function of phospholipase A2. J Biol Chem, 1994; 269:13057-13060
4. Farzaneh-Far A, Rudd J, and Weissberg PL: Inflammatory mechanisms. Br Med Bull, 2001; 59:55-68
5. Wang, YX and Fitch RM: Vascular stiffness: measurements, mechanisms and implications. Curr Vasc Pharmacol, 2004; 2:379-384
6. Wuyts FL, Vanhuyse VJ, Langewouters GJ, Decraemer WF, Raman ER, and Buyle S: Elastic properties of human aortas in relation to age and atherosclerosis: a structural model. Phys Med Biol, 1995; 40:1577-1597
7. Zieman SJ, Melenovsky V, and Kass DA: Mechanisms, pathophysiology, and therapy of arterial stiffness, Arterioscler Thromb Vasc Biol, 2005; 25:932-943
8. Volek JS, Sharman MJ, and Forsythe CE: Modification of lipoproteins by very low-carbohydrate diets. J Nutr, 2005; 135:1339-1342
9. Flower RJ and Perretti M: Controlling inflammation: a fat chance? J Exp Med, 2005; 201:671-674
10. Fernandez ML and Volek JS: Guinea pigs: a suitable animal model to study lipoprotein metabolism, atherosclerosis and inflammation. Nutr Metab (Lond), 2006; 3:17
11. Zern TL, West KL, and Fernandez ML: Grape polyphenols decrease plasma triglycerides and cholesterol accumulation in the aorta of ovariectomized guinea pigs. J Nutr, 2003; 133:2268-2272
12. West KL, Zern TL, Butteiger DN, Keller BTm and Fernandez ML: SC-435, an ileal apical sodium co-dependent bile acid transporter (ASBT) inhibitor lowers plasma cholesterol and reduces atherosclerosis in guinea pigs. Atherosclerosis, 2003; 171:201-210
13. Lin EC, Fernandez ML, and McNamara DJ: Dietary fat type and cholesterol quantity interact to affect cholesterol metabolism in guinea pigs. J Nutr, 1992; 122:2019-2029
14. Torres-Gonzalez M, Volek JS, Sharman M, Contois JH, and Fernandez ML: Dietary carbohydrate and cholesterol influence the number of particles and distributions of lipoprotein subfractions in guinea pigs. J Nutr Biochem, 2006; 17:773-779
15. Reynolds LJ, Hughes LL, and Dennis EA: Analysis of human synovial fluid phospholipase A2 on short chain phosphatidylcholine-mixed micelles: development of a spectrophotometric assay suitable for a microtiterplate reader. Anal Biochem, 1992; 204:190-197
16. Nosaka T, Tanaka H, Watanabe I, Sato M, and Matsuda M: Influence of regular exercise on age-related changes in arterial elasticity: mechanistic insights from wall compositions in rat aorta. Can J Appl Physiol, 2003; 28:204-212
17. Hayashi K, Washizu T, Tsushima N, Kiraly RJ, and Nose Y: Mechanical properties of aortas and pulmonary arteries of calves implanted with cardiac prostheses. J Biomech, 1981; 14:173-182
18. Wood RJ, Volek JS, Liu Y, Shachter NS, Contois JH, and Fernandez ML: Carbohydrate restriction alters lipoprotein metabolism by modifying VLDL, LDL, and HDL subfraction distribution and size in overweight men. J Nutr, 2006; 136:384-389
19. Leitinger N, Watson AD, Hama SY, Ivandic B, Qiao JH, Huber J, Faull KF, Grass DS, Navab M, Fogelman AM, de Beer FC, Lusis AJ, and Berliner JA: Role of group II secretory phospholipase A2 in atherosclerosis: 2. Potential involvement of biologically active oxidized phospholipids. Arterioscler Thromb Vasc Biol, 1999; 19:1291-1298
20. Krauss RM: Dense low density lipoproteins and coronary artery disease. Am J Cardiol, 1995; 75:53B-57B
21. Millar JS and Packard CJ: Heterogeneity of apolipoprotein B-100-containing lipoproteins: what we have learnt from kinetic studies, Curr Opin Lipidol, 1998; 9:197-202
22. Caslake MJ, Packard CJ, Suckling KE, Holmes SD, Chamberlain P, and Macphee CH: Lipoprotein-associated phospholipase A(2), platelet-activating factor acetylhydrolase: a potential new risk factor for coronary artery disease. Atherosclerosis, 2000; 150:413-419
23. Piñón P and Kaski JC: [Inflammation, atherosclerosis and cardiovascular disease risk: PAPP-A, Lp-PLA2 and cystatin C. New insights or redundant information?]. Rev Esp Cardiol, 2006; 59:247-258
24. Bowie A, Owens D. Collins P, Johnsons A, and Tomkin GH: Glycosylated low density, lipoproptein is more sensitivity to oxidation: implications for the diabetic patient? Atherosclerosis, 1993; 102:63-67
25. Bucala R, Makita Z, Viega G, Grundy S, Koschinsky T, Cerami A. and Vlassara H: Modification of low density lipoprotein by advanced glycation end products contributes to the dyslipidemia of diabetes and renal insufficiency. Proc Natl Acad Sci U S A, 1994; 91:9441-9445
26. Bucala R, Makita Z, Koschinsky T, Cerami A, and Vlassara H: Lipid advanced glycosylation pathway for lipid oxidation in vivo. Proc Natl Acad Sci U S A, 1993; 90:6434-6438
27. Witztum JL and Steinberg D: Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest, 1991; 88:1785-1792
28. Nilsson J: Regulating protective immunity in atherosclerosis. Circ Res, 2005; 96:395-397
29. Austin MA, Breslow JL, Hennekens CH, Buring JE, Willett WC, and Krauss RM, Low-density lipoprotein subclass patterns and risk of myocardial infarction. JAMA, 1988; 260:1971-1921
30. Lamarche B, Lemieux I, and Després JP: The small, dense LDL phenotype and the risk of coronary heart disease: epidemiology, patho-physiology and therapeutic aspects, Diabetes Metab, 1999; 25:199-211
31. Tribble DL, Rizzo M, Chait A, Lewis DM, Blanche PJ, and Krauss RM: Enhanced oxidative susceptibility and reduced antioxidant content of metabolic precursors of small, dense low-density lipoproteins. Am J Med, 2001; 110:103-110
32. Netea MG, Kullberg BJ, Demacker PN, Jacobs LE, Verver-Jansen TJ, Hijmans A, van Tits LH, Hoenderop JG, Willems PH, Van der Meer JW, and Stalenhoef AF: Native LDL potentiate TNF alpha and IL-8 production by human mononuclear cells. J Lipid Res, 2002;43:1065-1071
33. Aronson D and Rayfield EJ: How hyperglycemia promotes atherosclerosis: molecular mechanisms. Cardiovasc Diabetol, 2002;1:1
34. Bucala R, Mitchell R, Arnold K, Inneranty T, Vlassara H, and Cemi A. Identification of the major site of a polipoprotein B modification by advanced glycosylation end products blocking uptake by the low density lipoprotein receptor J Biol Chem. 1995; 270:10828-10832
35. Brownlee M, Cerami A, and Vlassara H, Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications, N Engl J Med, 1988; 318:1315-1321
36. Zhao J, Lu X, Zhuang F, and Gregersen H: Biomechemical and morphometric properties of the arterial wall referenced to the zero-stress state in experimental diabetes. Biorheology, 2000; 37:385-400
37. Katsuda S, Machida N, Hasegawa M, Miyashita H, Kusanagi M, Tsubone H, and Hazama A: Change in the static rheological properties of the aorta in Kurosawa and Kusanagi-hypercholesterolmic (KHC) rabbits with progress of atherosclerosis. Physiol Meas, 2004; 251:505-522
38. Cai WJ, Koltai S, Kocsis E, Scholz D, Kostin S, Luo X, Schaper W, and Schaper J: Remodeling of the adventitia during coronary arteriogenesis. Am J Physiol Heart Circ Physiol. 2003; 284:E31-H40
39. Keeling WB, Armstrong PA, Stone PA, Bandyk DF, and Shames ML: An overview of matrix metalloproteinases in the pathogenesis and treatment of abdominal aortic aneurysms. Vasc Endovascular Surg, 2005; 39:457-464
40. Shanahan CM and Weissberg PL: Smooth muscle cell phenotypes in atherosclerotic lesions. Curr Opin Lipidol, 1999; 10:507-513
41. Schram MT, Henry RM, van Dijk RA, Kostense PJ, Dekker JM, Nijpels G, Heine RJ, Bouter LM, Westerhof N and Stehouwer CD: Increased central artery stiffness in impaired glucose metabolism and type 2 diabetes: the Hoorn Study. Hypertension, 2004; 43:176-181
42. Sims TJ, Rasmussen LM, Oxlund H, and Bailey AJ: The role of glycation cross-links in diabetic vascular stiffening. Diabetologia, 1996; 39:946-951